Clinical Trials Browser

Carcinoma, Ovarian Epithelial, Ascites, Carcinoma, Fallopian Tube Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Peritoneal Neoplasms

NCT02638051 2017-05-19

OTMA-RII

Phase 2 Completed

260 enrolled 13 charts

Gynecologic

Ascites, Peritoneal Neoplasms, Yin Deficiency, Yang Deficiency

NCT02417753 2017-05-15

AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites

Phase 2 Terminated

1 enrolled 10 charts

GastrointestinalGynecologic

Ascites, Gastrointestinal Neoplasms, Ovarian Neoplasms

NCT02742428 2017-05-02

Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer

Phase NA Suspended

40 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Ascites, Malnutrition

NCT02811406 2016-06-23

The Role of Intravenous Albumin Replacement During Abdominal Paracentesis in Patients With Malignancy Related Ascites

Phase NA Unknown

100 enrolled

Ascites, Hypotension

NCT00327444 2013-01-01

Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites

Phase 2/3 Completed

58 enrolled 11 charts

Gynecologic

Ascites, Ovarian Neoplasms

NCT01150916 2012-12-20

B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites

Phase NA Completed

278 enrolled

Ascites, Carcinoma, Heart Failure, Liver Cirrhosis

NCT00005906 2010-04-30

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis

Phase 2 Completed

4 enrolled 8 charts

Thoracic

Ascites, Chylous Ascites, Chylothorax, Lymphangiomyoma, Pleural Effusion, Lymphangioleiomyomatosis

Clinical Trials

BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal

SOMAPROTECT01

KTMBO-RCT

Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites

ROLLON

TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites

Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites

OTMA-RII

AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites

Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer

The Role of Intravenous Albumin Replacement During Abdominal Paracentesis in Patients With Malignancy Related Ascites

Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites

B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis